placeholder

Press Releases

All Releases
View Summary Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009
Nov 6, 2009
PDF 19.9 KB
View Summary Insmed To Host Third Quarter 2009 Conference Call
Oct 22, 2009
PDF 9.9 KB
View Summary Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price
Sep 16, 2009
PDF 8.8 KB
View Summary Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009
Aug 13, 2009
PDF 18.6 KB
View Summary Insmed to Host Second Quarter 2009 Conference Call
Jul 31, 2009
PDF 9.8 KB
View Summary Insmed Provides Update on Supply of IPLEX(TM)
Jul 27, 2009
PDF 10.2 KB
View Summary Insmed Announces Addition to the Russell 3000(R) Index
Jun 30, 2009
PDF 8.5 KB
View Summary Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
Jun 25, 2009
PDF 11.9 KB
View Summary Insmed CEO Resigns Due to Health Concerns
Jun 15, 2009
PDF 10.4 KB
View Summary Insmed Announces First Quarter 2009 Financial Results
May 13, 2009
PDF 18.0 KB
View Summary Insmed Regains NASDAQ Compliance
May 5, 2009
PDF 8.5 KB
View Summary Insmed to Host First Quarter 2009 Conference Call
Apr 23, 2009
PDF 10.1 KB
View Summary Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Mar 31, 2009
PDF 10.0 KB
View Summary Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
Mar 30, 2009
 
View Summary Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
Mar 25, 2009
PDF 8.9 KB
View Summary Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
Mar 11, 2009
PDF 19.7 KB
View Summary Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
Mar 10, 2009
PDF 9.3 KB
View Summary Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
Feb 26, 2009
PDF 9.6 KB
View Summary Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Feb 12, 2009
PDF 12.5 KB
View Summary Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
Jan 21, 2009
PDF 11.8 KB
Showing 1-20 of 268 Page: 1 2 3 ... 14  Next 20

Press Releases

  • Nov 6, 2009
    Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009 Read More
  • Oct 22, 2009
    Insmed To Host Third Quarter 2009 Conference Call Read More